Back
iShares US Financials ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
89
IYF
iShares US Financials ETF
Last Price:
$116.96
Seasonality Move:
0.54%
Sell
50
RYTM
Rhythm Pharmaceuticals
Last Price:
$57.44
Seasonality Move:
54.9%
Buy
89
iShares US Financials ETF (IYF)
is a Buy
Is iShares US Financials ETF a Buy, Sell or Hold?
-
The current iShares US Financials ETF [IYF] share price is $115.82. The Score for IYF is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
-
IYF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
50
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $58.97. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IYF Stock Price Chart
What is iShares US Financials ETF's stock price today?
-
The iShares US Financials ETF share price today is $115.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IYF is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $58.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.
IYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.38 | Buy |
Relative Strength Index (14 RSI): | 65.44 | Buy |
Chaikin Money Flow: | 6705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.09 - 112.45) | Buy |
Bollinger Bands (100): | (107.95 - 116.93) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 46.88 | Sell |
Chaikin Money Flow: | 27337 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.61 - 64.05) | Sell |
Bollinger Bands (100): | (52.9 - 60.74) | Buy |
IYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.75 | Buy |
20-day SMA: | 109.62 | Buy |
50-day SMA: | 110.09 | Buy |
200-day SMA: | 109.3 | Buy |
8-day EMA: | 112.82 | Buy |
20-day EMA: | 110.85 | Buy |
50-day EMA: | 110.7 | Buy |
200-day EMA: | 107.91 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.08 | Sell |
20-day SMA: | 62.15 | Sell |
50-day SMA: | 56.78 | Buy |
200-day SMA: | 54.27 | Buy |
8-day EMA: | 61.17 | Sell |
20-day EMA: | 61 | Sell |
50-day EMA: | 58.76 | Buy |
200-day EMA: | 53.68 | Buy |
iShares US Financials ETF Earnings Growth & IYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
iShares US Financials ETF Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |